80320 Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices 

Non-voting Federal Liaisons, without 

limit, may be solicited, as needed, as ex 

officio members. 

Equal opportunity practices regarding 

membership appointments to the 

Committee will be aligned with HHS 

policies. To the extent possible, HHS 

will ensure the Committee membership 

is balanced in expertise, experience, 

education, and institutional affiliation. 

Members of the Committee will be 

classified as Special Government 

Employees (SGE) during their term of 

appointment and, as such, are subject to 

the ethical standards of conduct for 

federal employees. Upon entering the 

position and annually throughout the 

term of appointment, members of the 

Committee will be required to complete 

and submit a report of their financial 

holdings. 

Nominations and Appointments for 

Memberships: Nominees, including selfnominees, will be considered for 

appointment as members of the 

Committee. Only complete nomination 

packages submitted on time will be 

considered. To be considered for an 

appointment, submission of the 

following information for each nominee 

is required: (1) a cover letter that clearly 

states the name and place of work of the 

nominee, the rationale for the 

nomination, and a statement that the 

nominee would be willing to serve as a 

member of the Committee, if selected; 

(2) the name, address, telephone 

number, and email address for the 

individual being nominated and the 

nominator, if applicable; and (3) a copy 

of the nominee’s resume or curriculum 

vitae. Nominees with no professional 

affiliation may submit an optional letter 

of recommendation. 

The curriculum vitae should include 

the following information: (a) education; 

(b) experience (current and former); (c) 

affiliations; (d) current memberships 

(expert panels, committees, or other 

relevant groups, including positions 

held); (e) any peer-reviewed 

publications (for past 5 years); (f) any 

oral presentations (for past 5 years); (g) 

editorials, opinion pieces, and blogs (for 

past 5 years); (h) grants, contracts, or 

research funding (for past 15 years); (i) 

name of any corporation, professional 

society, association, panel, company, 

firm, government agency (Federal, State, 

and local), research organization, 

educational institution, committee, or 

other organization or institution 

(government, private, and not-for-profit; 

domestic and foreign) in which the 

nominee’s services have been, will be, 

or are expected to be provided, with or 

without compensation, including on a 

part-time or seasonal basis as an officer, 

medical staff, board member, owner, 

trustee, director, expert advisor, 

consultant (paid or unpaid), official 

spokesperson, member of speakers 

bureau, or expert witness (for past 5 

years and upcoming); (j) other paid 

travel or honoraria received, not 

included above (for past 5 years). If the 

nominee does not have anything to 

report for the sections, indicate ‘‘none.’’ 

Web links to publications, 

presentations, and other materials 

available online are requested, when 

available. 

Where prohibited by Federal law or 

regulations, nominations will not be 

accepted directly from HHS research 

and promotion boards. Self-nominations 

and nominations by members of 

research and promotion boards in their 

individual capacity will be considered. 

Federal employees should not be 

nominated for consideration for 

appointment to this Committee. 

Dated: November 2, 2023. 

Xavier Becerra, 

Secretary, Department of Health and Human 

Services. 

[FR Doc. 2023–24586 Filed 11–16–23; 8:45 am] 

BILLING CODE 4150–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Neurological Disorders and Stroke 

Special Emphasis Panel, November 27, 

2023, 09:00 a.m. to November 29, 2023, 

06:00 p.m., Crowne Plaza National 

Airport, 1480 Crystal Drive, Arlington, 

VA 22202 which was published in the 

Federal Register on September 25, 2023, 

88 FR 67334. 

This notice is being amended to 

change the location to Canopy by 

Hilton, 940 Rose Avenue, North 

Bethesda, MD 20852, and change the 

meeting times to 10:00 a.m. to 6:00 p.m. 

The meeting dates remains the same. 

The meeting is closed to the public. 

Dated: November 13, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–25403 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Amended Notice 

of Meeting 

Notice is hereby given of an amended 

meeting notice of the Advisory 

Committee to the Director, National 

Institutes of Health, December 14–15, 

2023, open meeting that was published 

in the Federal Register on November 13, 

2023, 88 FR 77595. 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Advisory Committee to 

the Director, National Institutes of 

Health. 

This will be a hybrid meeting held inperson and virtually and will be open to 

the public as indicated below. Members 

of the public are encouraged to attend 

virtually as space is limited. 

Individuals who plan to attend as 

well as those who need special 

assistance or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. The meeting can be 

accessed from the NIH Videocast at the 

following link: https://

videocast.nih.gov/ as space is limited. 

Name of Committee: Advisory Committee 

to the Director, National Institutes of Health. 

Date: December 14, 2023. 

Time: 9:00 a.m. to 4:45 p.m. 

Agenda: NIH Director’s Report; NIH Public 

Access Plan; Cancer Moonshot; Addressing 

the Mental Health Crisis through Research; 

Assessing the Public Health Threat of PostAcute Sequelae of SARS CoV–2 Infection 

(PASC)—NIH RECOVER Initiative: Briefing 

for the Advisory Committee to the Director 

(ACD); The Foundation for the National 

Institutes of Health (FNIH); Other Business of 

the Committee. 

Date: December 15, 2023. 

Time: 9:00 a.m. to 2:45 p.m. 

Agenda: HeLa Genome Data Access 

Working Group: Data Access Requests; NIHWide Collaborative Initiative on Climate 

Change and Health; Clinical Trial 

Stewardship; Accessibility Update; Update 

from the ACD Working Group on Catalyzing 

the Development and Use of Novel 

Alternative Methods to Advance Biomedical 

Research; Update from the ACD Working 

Group on Re-envisioning NIH-Supported 

Postdoctoral Training; Other Business of the 

Committee. 

Place: National Institutes of Health, 

Building 1, Wilson Hall, One Center Drive, 

Bethesda, MD 20892. 

Contact Person: Cyndi Burrus-Shaw, Staff 

Assistant, National Institutes of Health, 

Office of the Director, One Center Drive, 

Building 1, Room 126, Bethesda, MD 20892, 

301–496–2433, shawcy@od.nih.gov 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices 80321 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

acd.od.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: November 13, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–25376 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Neurological Disorders and Stroke 

Special Emphasis Panel, November 17, 

2023, 10:00 a.m. to 04:00 p.m., National 

Institutes of Health, Neuroscience 

Center, 6001 Executive Boulevard, 

Rockville, MD 20852 which was 

published in the Federal Register on 

November 3, 2023, 88 FR 77102. 

This notice is being amended to 

change this one-day meeting from 

November 17, 2023, to November 27, 

2023. The meeting time remains the 

same. The meeting is closed to the 

public. 

Dated: November 13, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–25404 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Establishment of the Board of 

Scientific Counselors, Division of 

Translational Toxicology, National 

Institute of Environmental Health 

Sciences 

Pursuant to the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

1001–1014), the Director, National 

Institutes of Health (NIH) announces the 

establishment of the Board of Scientific 

Counselors, Division of Translational 

Toxicology, National Institute of 

Environmental Health Sciences, as 

authorized by 42 U.S.C. 282(b)(16), 

section 402(b)(16) of the Public Health 

Service Act, as amended. 

The Director, NIH, has determined 

that the Board of Scientific Counselors, 

Division of Translational Toxicology, 

National Institute of Environmental 

Health Sciences is in the public interest 

in connection with the performance of 

duties imposed on NIH by law, and that 

these duties can best be performed 

through the advice and counsel of the 

committee. 

The committee will review and 

evaluate the intramural program and the 

work of tenured, tenure track, and staff 

scientists and physicians and shall also, 

as requested by the Director, NIH, 

undertake peer review of extramural 

funding applications as required by 

section 492 of the Public Health Service 

Act, as amended. 

Inquiries may be directed to Claire 

Harris, Director, Office of Federal 

Advisory Committee Policy, Office of 

the Director, National Institutes of 

Health, 6701 Democracy Boulevard, 

Suite 1000, Bethesda, Maryland 20892 

(Mail code 4875), Telephone (301) 496– 

2123, or Claire.Harris@nih.gov. 

Dated: November 13, 2023. 

Monica M. Bertagnolli, 

Director, National Institutes of Health. 

[FR Doc. 2023–25472 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; CTSA Collaborative and 

Innovative Acceleration Awards. 

Date: February 7, 2024. 

Time: 11:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: M. Lourdes Ponce, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, Room 

1068, Bethesda, MD 20892, (301) 435–0810, 

lourdes.ponce@nih.gov. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; Understudied Proteins 

Associated with Rare Diseases (R03) Review. 

Date: February 29, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ming Yan, MD, Ph.D. 

Scientific Review Officer Scientific Review 

Branch Division of Extramural Activities 

National Center for Advancing Translational 

Sciences 6701 Democracy Boulevard, MSC 

4874 Bethesda, MD 20892 (301) 827–4312 

ming.yan@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 


khammond on DSKJM1Z7X2PROD with NOTICES